New blood purification therapy for sepsis under Real-World scrutiny

NCT ID NCT07388628

Recruiting now Disease control Sponsor: Artcline GmbH Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This registry study is following 200 adults with sepsis or septic shock who receive ARTICE® therapy in the ICU. Researchers are tracking organ function, survival, and complications to see how well the treatment works in everyday practice. The goal is to identify which patients benefit most and to better understand the therapy's safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ARTICE® therapy (a blood purification treatment for sepsis)
What this could lead to: If successful, this study could show that ARTICE® therapy helps sepsis patients recover faster and reduces organ failure.
What could go wrong: This is an observational registry, not a controlled trial, so results may be less conclusive. The therapy may not improve outcomes for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOPARALYSIS IN SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNOPARALYSIS IN SEPTIC SHOCK SEPSIS SEPTIC SHOCK

Contacts and locations

Locations

Johannes Wesling Klinikum, Universitätsklinik für Anästhesiologie, Intensiv & Notfallmedizin
RECRUITING

Minden, 32429, Germany
Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin
RECRUITING

Magdeburg, 39130, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.